M

Mangoceuticals Inc
NASDAQ:MGRX

Watchlist Manager
Mangoceuticals Inc
NASDAQ:MGRX
Watchlist
Price: 0.8785 USD 1.09% Market Closed
Market Cap: 12.2m USD

Mangoceuticals Inc
Investor Relations

Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Jacob D. Cohen
Co-Founder, CEO & Chairman
No Bio Available
Mr. Eugene M. Johnston
Chief Financial Officer
No Bio Available
Ms. Amanda Elizabeth Hammer
Chief Operating Officer
No Bio Available

Contacts

Address
TEXAS
Dallas
4131 N Central Expy, Ste 900
Contacts
+18336264679
www.mangorx.com